Should Wall Street be worried about Monkeypox

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

The World Health Organization reported 92 cases in 12 countries as of Saturday, with another 28 suspected cases under investigation. Cases have been confirmed in the United States, the United Kingdom, Canada, Australia, Germany, France, Italy, Spain, Sweden, Belgium, Portugal, and the Netherlands.

What exactly is Monkeypox?


Rashes, fever, headaches, muscle ache, swelling, and backpain are all symptoms of monkeypox, which is caused by the monkeypox virus, which is related to smallpox. Despite being less severe than smallpox, health experts are concerned about the origins of a recent outbreak that began in early May in countries outside of Central and West Africa. Health officials, including the Centers for Disease Control and Prevention in the United States and the Health Security Agency in the United Kingdom, said they’ve noticed a spike in cases among men who have sex with men, and urged gay and bisexual men to be aware of any unusual rashes or lesions.

The recent increase in community cases, especially in urban areas, has sparked fears of a larger outbreak.

“We have to figure out exactly what’s going on now,” Seth Berkley, CEO of global vaccine alliance Gavi, told CNBC Monday.

Recent reported cases, according to the public health agency (WHO), had no links to travel from endemic African countries, which is unusual for the disease. It usually spreads from person to person or animal to animal.